Results for tag: "Bromhidrosis Disease Drug"

Bromhidrosis Disease is a condition characterized by an unpleasant body odor caused by excessive sweating. It is classified as an endocrine and metabolic disorder, and is treated with drugs that target the underlying cause of the condition. These drugs are typically used to reduce the production of sweat, regulate hormones, and reduce inflammation. Commonly prescribed drugs include anticholinergics, antiperspirants, and topical corticosteroids. In some cases, oral medications such as antibiotics and antifungals may be prescribed. The Bromhidrosis Disease Drug market is a specialized segment of the Endocrine and Metabolic Disorders Drugs market. It is composed of a variety of drugs used to treat the condition, including anticholinergics, antiperspirants, topical corticosteroids, antibiotics, and antifungals. These drugs are typically prescribed by dermatologists and endocrinologists. Some companies in the Bromhidrosis Disease Drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more